John Hiemenz
- Infectious Diseases top 1%
- Epidemiology top 2%
- Oncology top 2%
- Clinical Biochemistry top 0.5%
- Pharmacology top 2%
- Co-authors
- Thomas J. WalshPhilip A. PizzoNita L. SeibelCarola ArndtStephen DummerRobert W. FinbergJohn S. HolcenbergWilliam E. Dismukes
- Topics
- Neutropenia and Cancer Infections (9 papers)Bacterial Identification and Susceptibility Testing (4 papers)Antifungal resistance and susceptibility (3 papers)
- Partner nations
- United StatesUkraineMalaysia
In The Last Decade
John Hiemenz
16 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Infectious Diseases 1.2k
- Epidemiology 1.1k
- Oncology 1.1k
- Clinical Biochemistry 515
- Pharmacology 386
Countries citing papers authored by John Hiemenz
This map shows the geographic impact of John Hiemenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hiemenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hiemenz more than expected).
Fields of papers citing papers by John Hiemenz
This network shows the impact of papers produced by John Hiemenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hiemenz. The network helps show where John Hiemenz may publish in the future.
Co-authorship network of co-authors of John Hiemenz
This figure shows the co-authorship network connecting the top 25 collaborators of John Hiemenz. A scholar is included among the top collaborators of John Hiemenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hiemenz. John Hiemenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 2 | |
| 6 | 31 | |
| 7 | 12 | |
| 8 | 1 | |
| 9 | 58 | |
| 10 | 97 | |
| 11 | 271 | |
| 12 | 265 | |
| 13 | Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropeniabreakdown → | 884 |
| 14 | 6 | |
| 15 | 59 | |
| 16 | A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropeniabreakdown → | 478 |
| 17 | 86 | |
| 18 | 23 | |
| 19 | 99 |
About John Hiemenz
John Hiemenz is a scholar working on Clinical Biochemistry, Hematology and Oncology, having authored 19 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (9 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Clinical Biochemistry (515 citations), Infectious Diseases (1.2k citations) and Oncology (1.1k citations). John Hiemenz has collaborated with scholars based in United States, Ukraine and Malaysia. Frequent co-authors include Thomas J. Walsh, Philip A. Pizzo, Nita L. Seibel, Carola Arndt, Stephen Dummer, Robert W. Finberg, John S. Holcenberg, William E. Dismukes, Peter G. Pappas and Cindy L. Schwartz. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.